SCHEMBL1167923

SCHEMBL1167923

c1ccc(-c2cc(-c3ccccc3)cc(C3(c4cc(-c5ccccc5)cc(-c5ccccc5)c4)c4ccccc4-c4ccccc43)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 1/20 0.48
OPRK1 P41145 1/20 0.48
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
PDK2 Q15119 9/20 0.42
THRB P10828 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.37
APAF1 O14727 1/20 0.34
NPC1 O15118 1/20 0.34
XBP1 P17861 1/20 0.34
PTBP1 P26599 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19020415 1.00 MEN1 (0.48) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL12166295 0.89 MEN1 (0.44) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL12166312 0.87 MEN1 (0.42) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL29307108 0.87 ABL1 (0.47) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL12166498 0.87 MEN1 (0.39) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL15966167 0.86 ESR1 (0.47) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL2606147 0.86 MAPT (0.43) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL12166303 0.85 MEN1 (0.41) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL29307111 0.85 LMNA (0.46) MEN1KMT2ALMNAMAPTSMN1; SMN2
SCHEMBL2606149 0.85 KDM4E (0.38) MEN1KMT2ALMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8361638-B2 Fluorine derivatives for organic electroluminescence devices MERCK PATENT GMBH (DE) 2013-01-29 US disclosed
EP-2260023-B1 FLUORENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2012-04-25 EP disclosed
US-20110037027-A1 FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2011-02-17 US disclosed
EP-2260023-A1 FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES Merck Patent GmbH (DE) 2010-12-15 EP disclosed
WO-2009124627-A1 FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2009-10-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110037027-A1 FLUORINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENCE DEVICES SLCO4C1, CTCF, AFF2 MEN1 428/4885KMT2A 847/4885LMNA 2309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.